再生醫療的全球市場:各治療方法 (細胞療法，遺傳基因療法)、產品 (自我細胞/同種異體細胞/無細胞)、用途、地區的預測
Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology) & By Region-Forecast (2016-2021)
|出版日期||內容資訊||英文 136 Pages
|再生醫療的全球市場:各治療方法 (細胞療法，遺傳基因療法)、產品 (自我細胞/同種異體細胞/無細胞)、用途、地區的預測 Regenerative Medicine Market: By Therapy (Cell Therapy, Gene Therapy), By Product (Autologous Cell-Based, Allogeneic Cell-Based, Acellular), By Application (Orthopaedic & Musculoskeletal Spine, Dermatology) & By Region-Forecast (2016-2021)|
|出版日期: 2016年09月19日||內容資訊: 英文 136 Pages||
Regenerative medicines are capable of restoring the functionality of cells & tissues by treating a patient with laboratory grown cells and tissues. Regenerative medicines are used in a wide range of degenerative disorders such as dermatology, neurodegenerative diseases, cardiovascular and orthopaedic applications. Globally, development of efficient and advance technology in tissue and organ regeneration, growing funding from government and private organizations to support the development of regenerative medicines products, rise in the awareness among people regarding regenerative medicine, increasing government initiative across the globe, and growing aging population and healthcare expenditure are the prime growth drivers of global regenerative medicine market. In addition, Emergence of utilization of nanomaterial in wound care, drug delivery, and immunomodulation, increase in adoption of regenerative medicine for peripheral artery diseases, and emerging economies such as China, India and others, will create new opportunities for global regenerative medicine market. However, higher cost of the research and development, and complex government approval processes are the key restraints for global regenerative medicine market.
Geographically North America dominated global regenerative medicine market because of high medical reimbursement facilities, and technological advancement. Asia Pacific is projected to have fastest growth, owing to rapidly increasing aging population and per capita healthcare expenditure, rise in consumer awareness, higher focus on research in regenerative medicines especially in Japan, favourable government policies, modernization of healthcare infrastructure, and growing medical tourism industry in developing nations such as China, and India in this region. Among all the application, orthopaedic & musculoskeletal spine segment has the highest market share in global regenerative medicine market due to higher prevalence of musculoskeletal cases and growing investments in orthopaedic research.
This report identifies the global regenerative medicine market size in for the year 2014-2016, and forecast of the same for year 2021. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to global regenerative medicine market.
Regenerative Medicine Market, By Therapy: Cell Therapy, Gene Therapy, Tissue Engineering, and Immunotherapy
Regenerative Medicine Market, By Product: Autologous Cell-Based Products, Allogeneic Cell-Based Products, and Acellular Products
The report has focused study on regenerative medicine market by basis of application such as: Orthopedic & Musculoskeletal Spine, Dermatology, Cardiovascular, Central Nervous System, Oncology, Diabetes, and Others
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region
Japan Tissue Engineering Co., Ltd
Vertex Pharmaceuticals Incorporated
Cytori Therapeutics Inc.
Acelity (KCI Licensing)
More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"